BISPECIFIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD20 AND BCMA
Application
US20260076995A1
Kind: A1
Mar 19, 2026
Assignee
ABELZETA INC.
Inventors
Yihong YAO, Jiaqi HUANG, Shigui ZHU, Xin YAO, Xiaobing LUO, Yutian WEI
Abstract
The present disclosure provides bispecific chimeric antigen receptors targeting CD20 and BCMA. The CAR may comprise an scFv targeting CD20 and an scFv targeting BCMA, a hinge region, a transmembrane domain, a co-stimulatory region, and a cytoplasmic signaling domain. The chimeric antigen receptors can be used to treat autoimmune disorders or cancer.
CPC Classifications
A61K 35/17
A61K 40/11
A61K 40/15
A61K 40/31
A61K 40/4202
A61K 40/4215
A61K 40/4221
A61K 40/4224
A61P 35/00
A61P 37/02
A61P 37/06
C07K 16/2878
C07K 16/2887
C12N 5/0636
A61K 2239/13
A61K 2239/21
A61K 2239/22
A61K 2239/29
C07K 2317/31
C07K 2317/53
C07K 2317/622
C07K 2319/03
C12N 2510/00
Filing Date
2025-10-02
Application No.
19348065